Cargando…
A 6-month follow-up study of the randomized controlled Ma-Pi macrobiotic dietary intervention (MADIAB trial) in type 2 diabetes
BACKGROUND: In the MADIAB trial (a 21-day randomized, controlled trial in patients with type 2 diabetes (T2D)), intervention with the Ma-Pi 2 macrobiotic diet resulted in significantly greater improvements in metabolic control compared with a standard recommended diet for patients with T2D. We repor...
Autores principales: | Soare, A, Del Toro, R, Khazrai, Y M, Di Mauro, A, Fallucca, S, Angeletti, S, Skrami, E, Gesuita, R, Tuccinardi, D, Manfrini, S, Fallucca, F, Pianesi, M, Pozzilli, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022142/ https://www.ncbi.nlm.nih.gov/pubmed/27525817 http://dx.doi.org/10.1038/nutd.2016.29 |
Ejemplares similares
-
The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial
por: Soare, Andreea, et al.
Publicado: (2014) -
The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trial
por: Soare, Andreea, et al.
Publicado: (2015) -
Modulation of gut microbiota dysbioses in type 2 diabetic patients by
macrobiotic Ma-Pi 2 diet
por: Candela, Marco, et al.
Publicado: (2016) -
Medium- and Short-Term Interventions with Ma-Pi 2 Macrobiotic Diet in Type 2 Diabetic Adults of Bauta, Havana
por: Porrata-Maury, Carmen, et al.
Publicado: (2012) -
Gut macrobiotic and its metabolic pathways modulate cardiovascular disease
por: Zhu, Junwen, et al.
Publicado: (2023)